Details for New Drug Application (NDA): 205660
✉ Email this page to a colleague
The generic ingredient in ENOXAPARIN SODIUM (PRESERVATIVE FREE) is enoxaparin sodium. There are thirteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the enoxaparin sodium profile page.
Summary for 205660
Tradename: | ENOXAPARIN SODIUM (PRESERVATIVE FREE) |
Applicant: | Shenzhen Techdow |
Ingredient: | enoxaparin sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 205660
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 205660 | ANDA | Sandoz Inc. | 0781-3460 | 0781-3460-63 | 10 SYRINGE in 1 CARTON (0781-3460-63) / .3 mL in 1 SYRINGE (0781-3460-01) |
ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 205660 | ANDA | Sandoz Inc. | 0781-3482 | 0781-3482-63 | 10 SYRINGE in 1 CARTON (0781-3482-63) / .4 mL in 1 SYRINGE (0781-3482-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;SUBCUTANEOUS | Strength | 30MG/0.3ML (100MG/ML) | ||||
Approval Date: | Mar 15, 2023 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;SUBCUTANEOUS | Strength | 40MG/0.4ML (100MG/ML) | ||||
Approval Date: | Mar 15, 2023 | TE: | AP | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;SUBCUTANEOUS | Strength | 60MG/0.6ML (100MG/ML) | ||||
Approval Date: | Mar 15, 2023 | TE: | AP | RLD: | No |
Complete Access Available with Subscription